
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Jun 15, 2026 - 25:13
Radio and PodcastLive Radio & Podcasts
The second ousting of Vinay Prasad from FDA in the past eight months won’t lead to major changes at the agency, other than selecting a successor tasked with keeping FDA out of the news ahead of the coming midterm electio...
Ep. 353 - Prasad Departure and Future of Fibrosis Therapies is an episode from BioCentury This Week by BioCentury. The second ousting of Vinay Prasad from FDA in the past eight months won’t lead to major changes at the agency, other than se...
This episode belongs to BioCentury This Week.
Use the player on this page to stream the episode online.
Published Mar 9, 2026, 37:04 long, audio available.